Nexstim Plc (HEL:NXTMH)
14.05
-0.10 (-0.71%)
Nov 17, 2025, 6:24 PM EET
Nexstim Revenue
Nexstim had revenue of 5.37M EUR in the half year ending June 30, 2025, with 69.24% growth. This brings the company's revenue in the last twelve months to 11.63M, up 24.18% year-over-year. In the year 2024, Nexstim had annual revenue of 10.21M with 18.97% growth.
Revenue (ttm)
11.63M
Revenue Growth
+24.18%
P/S Ratio
8.71
Revenue / Employee
290.74K
Employees
40
Market Cap
101.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.21M | 1.63M | 18.97% |
| Dec 31, 2023 | 8.58M | -2.18M | -20.23% |
| Dec 31, 2022 | 10.76M | 3.21M | 42.44% |
| Dec 31, 2021 | 7.56M | 3.40M | 81.87% |
| Dec 31, 2020 | 4.15M | 767.53K | 22.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Oriola Oyj | 1.85B |
| Orion Oyj | 1.63B |
| Terveystalo Oyj | 1.30B |
| Pihlajalinna Oyj | 684.22M |
| Revenio Group Oyj | 109.32M |
| Optomed Oyj | 17.38M |
| Biohit Oyj | 14.28M |
| Nanoform Finland Oyj | 4.89M |